LabCompass

Wenwen Du

Medicine · Indiana University

Publications

72

Citations

2,201

Est. group size

Recurring co-author estimate

Active years

15

Publishing since 2012

Research summary
AI-generated

Wenwen Du studies clinical pharmacology in the context of lung transplantation, focusing on how drugs like tacrolimus, voriconazole, and statins are dosed, processed by the body, and linked to patient outcomes. Much of the work uses genetic information and predictive models to anticipate complications such as kidney injury and chronic allograft dysfunction after transplantation. Additional work touches on cancer biology, cost-effectiveness analyses of cancer therapies, and analytical laboratory methods for measuring drugs.

Lung transplantation outcomesClinical pharmacology and drug dosingGenotype-guided prediction modelsCancer therapy and immunotherapyAnalytical drug measurement methods

Publication activity has been broadly steady with fluctuations, averaging about seven papers per year over the last five years and peaking around 2020 and 2024.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.2/year recently
2017: 2 publications172018: 2 publications182019: 7 publications192020: 13 publications13202021: 4 publications212022: 6 publications222023: 9 publications232024: 13 publications13242025: 5 publications252026: 3 publications26
Recent publications
Publishes in
  • Research Square×4
  • The Journal of Clinical Pharmacology×3
  • European Journal of Clinical Pharmacology×2
  • Scientific Reports×2
  • Pulmonary Pharmacology & Therapeutics×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile